These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Vitiligo and malignant melanoma: a significant association? Gregor RT. S Afr Med J; 1976 Aug 28; 50(3F):1447-9. PubMed ID: 973163 [Abstract] [Full Text] [Related]
5. Metastatic melanoma and vitiligo: a case report. Buljan M, Situm M, Lugović L, Vucić M. Acta Dermatovenerol Croat; 2006 Aug 28; 14(2):100-3. PubMed ID: 16859616 [Abstract] [Full Text] [Related]
6. Direct evidence to support the role of antigen-specific CD8(+) T cells in melanoma-associated vitiligo. Le Gal FA, Avril MF, Bosq J, Lefebvre P, Deschemin JC, Andrieu M, Dore MX, Guillet JG. J Invest Dermatol; 2001 Dec 28; 117(6):1464-70. PubMed ID: 11886510 [Abstract] [Full Text] [Related]
7. Vitiligo associated with malignant melanoma and lupus erythematosus. Gül U, Kiliç A, Tulunay O, Kaygusuz G. J Dermatol; 2007 Feb 28; 34(2):142-5. PubMed ID: 17239155 [Abstract] [Full Text] [Related]
8. Coexisting malignant melanoma and vitiligo in a Nigerian. Alabi GO, Falope ZF, Lekwauwa UG. West Afr J Med; 1991 Feb 28; 10(1):443-6. PubMed ID: 2069894 [Abstract] [Full Text] [Related]
9. Hypopigmentation, vitiligo, and melanoma. New data, more enigmas. Nordlund JJ. Arch Dermatol; 1987 Aug 28; 123(8):1005-8. PubMed ID: 3631979 [No Abstract] [Full Text] [Related]
10. Immunological basis of melanoma-associated vitiligo-like depigmentation. González R, Torres-López E. Actas Dermosifiliogr; 2014 Mar 28; 105(2):122-7. PubMed ID: 23146137 [Abstract] [Full Text] [Related]
11. Complete regression of melanoma associated with vitiligo. Piqué-Duran E, Palacios-Llopis S, Martínez-Martín M, Pérez-Cejudo JA. Dermatol Online J; 2011 Jan 15; 17(1):4. PubMed ID: 21272495 [Abstract] [Full Text] [Related]
12. Vitiligo associated with metastatic malignant melanoma. Cavallari V, Cannavò SP, Ussia AF, Moretti G, Albanese A. Int J Dermatol; 1996 Oct 15; 35(10):738-40. PubMed ID: 8891830 [No Abstract] [Full Text] [Related]
13. Vitiliginous achromia with malignant melanoma. Tyrosinase activity and ultrastructural study of achromic and normal skin. Perrot H, Ortonne JP, Schmitt D. Arch Dermatol Res (1975); 1977 Jan 31; 257(3):247-53. PubMed ID: 402121 [Abstract] [Full Text] [Related]
14. Risk of internal malignancies, cutaneous malignant melanoma and non-melanoma skin cancer among patients with vitiligo: a systematic review and meta-analysis. Long VS, Law YXT, Yew YW, Choi CE. J Eur Acad Dermatol Venereol; 2022 Oct 31; 36(10):e829-e831. PubMed ID: 35686630 [No Abstract] [Full Text] [Related]
15. Vitiligo and malignant melanoma. Fodor J, Bodrogi I. Neoplasma; 1975 Oct 31; 22(4):445-8. PubMed ID: 1196428 [Abstract] [Full Text] [Related]
17. Vitiligo or halo nevi occurring in two patients with choroidal melanoma. Albert DM, Todes-Taylor N, Wagoner M, Nordlund JJ, Lerner AB. Arch Dermatol; 1982 Jan 31; 118(1):34-6. PubMed ID: 7059198 [Abstract] [Full Text] [Related]
18. Malignant melanoma and vitiligo. Milton GW, McCarthy WH, Carlon A. Australas J Dermatol; 1971 Dec 31; 12(3):131-42. PubMed ID: 5146927 [No Abstract] [Full Text] [Related]
19. Autoimmunity as an aetiological factor in vitiligo. Rezaei N, Gavalas NG, Weetman AP, Kemp EH. J Eur Acad Dermatol Venereol; 2007 Aug 31; 21(7):865-76. PubMed ID: 17658994 [Abstract] [Full Text] [Related]
20. Vitiligo in patients with metastatic melanoma: a good prognostic sign. Nordlund JJ, Kirkwood JM, Forget BM, Milton G, Albert DM, Lerner AB. J Am Acad Dermatol; 1983 Nov 31; 9(5):689-96. PubMed ID: 6643767 [Abstract] [Full Text] [Related] Page: [Next] [New Search]